James E. Rowedder
34 works · 696 citations · h-index 13
Top works
- Production of mouse epidermal growth factor in yeast: high-level secretion using Pichia pastoris strains containing multiple gene copies
- Direct Measurement of the Binding of RAS to Neurofibromin Using a Scintillation Proximity Assay
- Development of a small molecule that corrects misfolding and increases secretion of Z α1‐antitrypsin
- Discovery of (S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αvβ6 Integrin Inhibitor for the Inhaled Treatment of Idiopathic Pulmonary Fibrosis
- Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents
- Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic pain
- Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target
- Relative Binding Affinities of Integrin Antagonists by Equilibrium Dialysis and Liquid Chromatography–Mass Spectrometry
- Determining the True Selectivity Profile of αv Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem
- Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach
- A high-throughput MALDI-TOF MS biochemical screen for small molecule inhibitors of the antigen aminopeptidase ERAP1
- Late‐Stage Functionalization by Chan–Lam Amination: Rapid Access to Potent and Selective Integrin Inhibitors
- Design of Phthalazinone Amide Histamine H1 Receptor Antagonists for Use in Rhinitis
- Free–Wilson Analysis of Comprehensive Data on Phosphoinositide-3-kinase (PI3K) Inhibitors Reveals Importance of N ‑Methylation for PI3Kδ Activity
- Discovery of an Orally Bioavailable Pan αv Integrin Inhibitor for Idiopathic Pulmonary Fibrosis
- Design and Development of a Macrocyclic Series Targeting Phosphoinositide 3-Kinase δ
- The development of highly potent and selective small molecule correctors of Z α1-antitrypsin misfolding
- The discovery of quinoline based single-ligand human H1 and H3 receptor antagonists
- The Design of Potent, Selective and Drug‐Like RGD αvβ1 Small‐Molecule Inhibitors Derived from non‐RGD α4β1 Antagonists
- Discovery of the first potent and selective αvβ5 integrin inhibitor based on an amide-containing core